These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 37665139

  • 21. Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma.
    Luerken L, Haimerl M, Doppler M, Uller W, Beyer LP, Stroszczynski C, Einspieler I.
    Rofo; 2022 Oct; 194(10):1075-1086. PubMed ID: 35545102
    [Abstract] [Full Text] [Related]

  • 22. Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis.
    Abdelaziz AO, Nabeel MM, Elbaz TM, Shousha HI, Hassan EM, Mahmoud SH, Rashed NA, Ibrahim MM, Abdelmaksoud AH.
    Scand J Gastroenterol; 2015 Apr; 50(4):479-84. PubMed ID: 25592058
    [Abstract] [Full Text] [Related]

  • 23. Drug-eluting bead trans-arterial chemoembolization combined with microwave ablation therapy vs. microwave ablation alone for early stage hepatocellular carcinoma: a preliminary investigation of clinical value.
    Liu J, Zhang W, Lu H, Li H, Zhou X, Li J, Han X.
    J Cancer Res Clin Oncol; 2022 Jul; 148(7):1781-1788. PubMed ID: 34405295
    [Abstract] [Full Text] [Related]

  • 24. Comparison of combined transarterial chemoembolization and ablations in patients with hepatocellular carcinoma: a systematic review and meta-analysis.
    Keshavarz P, Raman SS.
    Abdom Radiol (NY); 2022 Mar; 47(3):1009-1023. PubMed ID: 34982183
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Radiofrequency versus microwave ablation for hepatocellular carcinoma within the Milan criteria in challenging locations: a retrospective controlled study.
    Han X, Ni JY, Li SL, Deng HX, Liang HM, Xu YY, Huang ZM, Zhang TQ, Huang JH.
    Abdom Radiol (NY); 2021 Aug; 46(8):3758-3771. PubMed ID: 34032898
    [Abstract] [Full Text] [Related]

  • 27. Microwave ablation combined with lipiodol-microsphere mixed or conventional transarterial chemoembolization for the treatment of colorectal liver metastases: A retrospective study.
    Shi Q, Wang F, Du N, Zhou Y, Zhou X, Ma J, Yang M, Zhang Z, Yu J, Zhang W, Luo J, Liu L, Yan Z.
    Clin Res Hepatol Gastroenterol; 2022 Aug; 46(7):101986. PubMed ID: 35772684
    [Abstract] [Full Text] [Related]

  • 28. Microwave ablation versus sorafenib for intermediate-Stage Hepatocellular carcinoma with transcatheter arterial chemoembolization refractoriness: a propensity score matching analysis.
    Chen S, Shi M, Shen L, Qi H, Wan W, Cao F, Xie L, Wu Y, Chen G, Mo J, Zhu G, Ye D, Zhang Y, Feng Z, Xu L, Fan W.
    Int J Hyperthermia; 2020 Aug; 37(1):384-391. PubMed ID: 32323585
    [Abstract] [Full Text] [Related]

  • 29. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
    Thornton LM, Cabrera R, Kapp M, Lazarowicz M, Vogel JD, Toskich BB.
    Curr Probl Diagn Radiol; 2017 Aug; 46(6):402-409. PubMed ID: 28392205
    [Abstract] [Full Text] [Related]

  • 30. Microwave ablation for hepatocellular carcinoma associated with Budd-Chiari syndrome after transarterial chemoembolization: an analysis of ten cases.
    Dou JP, Yu J, Han ZY, Liu FY, Cheng ZG, Liang P.
    Abdom Radiol (NY); 2017 Mar; 42(3):962-968. PubMed ID: 27688061
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Liver Resection versus Radiofrequency Ablation plus Transcatheter Arterial Chemoembolization in Cirrhotic Patients with Solitary Large Hepatocellular Carcinoma.
    Saviano A, Iezzi R, Giuliante F, Salvatore L, Mele C, Posa A, Ardito F, De Gaetano AM, Pompili M, HepatoCATT Study Group.
    J Vasc Interv Radiol; 2017 Nov; 28(11):1512-1519. PubMed ID: 28734848
    [Abstract] [Full Text] [Related]

  • 33. Microwave ablation shows similar survival outcomes compared with surgical resection for hepatocellular carcinoma between 3 and 5 cm.
    Zheng H, Xu C, Wang X, Li J, Zhao X, Qi J, Feng Y, Zhu Q.
    Int J Hyperthermia; 2020 Nov 12; 37(1):1345-1353. PubMed ID: 33289415
    [Abstract] [Full Text] [Related]

  • 34. Liver stiffness measurement changes following hepatocellular carcinoma treatment with percutaneous microwave ablation or transarterial chemoembolization: a cohort study.
    Abdelaziz AO, Abdelhalim H, Elsharkawy A, Shousha HI, Abdelmaksoud AH, Soliman ZA, Seif MI, Sayed DB, Farouk MH, Elbaz TM, Nabeel MM.
    Eur J Gastroenterol Hepatol; 2019 Jun 12; 31(6):685-691. PubMed ID: 30640743
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of microwave ablation versus radiofrequency ablation for hepatocellular carcinoma: a propensity score analysis.
    Suwa K, Seki T, Aoi K, Yamashina M, Murata M, Yamashiki N, Nishio A, Shimatani M, Naganuma M.
    Abdom Radiol (NY); 2021 Aug 12; 46(8):3790-3797. PubMed ID: 33675382
    [Abstract] [Full Text] [Related]

  • 36. Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance.
    Shi Q, Zhou X, Zhang Z, Zhang W, Ma J, Yang M, Yu J, Luo J, Liu L, Yan Z.
    Front Immunol; 2022 Aug 12; 13():1097625. PubMed ID: 36703965
    [Abstract] [Full Text] [Related]

  • 37. A nomogram to predict survival of patients with intermediate-stage hepatocellular carcinoma after transarterial chemoembolization combined with microwave ablation.
    Ni JY, Fang ZT, Sun HL, An C, Huang ZM, Zhang TQ, Jiang XY, Chen YT, Xu LF, Huang JH.
    Eur Radiol; 2020 Apr 12; 30(4):2377-2390. PubMed ID: 31900694
    [Abstract] [Full Text] [Related]

  • 38. Current status of the combination therapy of transarterial chemoembolization and local ablation for hepatocellular carcinoma.
    Li W, Ni CF.
    Abdom Radiol (NY); 2019 Jun 12; 44(6):2268-2275. PubMed ID: 31016345
    [Abstract] [Full Text] [Related]

  • 39. Adjuvant cytokine-induced killer cells with minimally invasive therapies augmented therapeutic efficacy of unresectable hepatocellular carcinoma.
    Huang ZM, Lai CX, Zuo MX, An C, Wang XC, Huang JH, Ning E.
    J Cancer Res Ther; 2020 Jun 12; 16(7):1603-1610. PubMed ID: 33565506
    [Abstract] [Full Text] [Related]

  • 40. Comparison of combination therapies in the management of hepatocellular carcinoma: transarterial chemoembolization with radiofrequency ablation versus microwave ablation.
    Ginsburg M, Zivin SP, Wroblewski K, Doshi T, Vasnani RJ, Van Ha TG.
    J Vasc Interv Radiol; 2015 Mar 12; 26(3):330-41. PubMed ID: 25534635
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.